Rodolà F, Vagnoni S, Ingletti S
Facoltà di Medicina e Chirurgia, Istituto di Anestesiologia e Rianimazione, Università Cattolica del Sacro Cuore-Rome, Italy.
Eur Rev Med Pharmacol Sci. 2003 Sep-Oct;7(5):131-8.
Intravenous Regional Anaesthesia (IVRA) has been first described in 1908 by the german surgeon August KG Bier. Although the technique was easy to perform and effective in giving surgical anaesthesia, the newer plexus block techniques largely replaced in a short time the "Bier block", because of time limitations of IVRA and safety considerations. Throughout the years modifications in procedure and new pharmacologic adjuvants have been shown to prevent toxic reactions to anaesthetics and mitigate limitations of IVRA. This paper rewiews the technique itself, its historical background, procedural modifications to improve its safety and efficiency, pharmacologic adjuvants acting on onset time of anaesthesia and on tourniquet pain, and drugs improving postoperative analgesia and muscle relaxation. The economic side of IVRA is also discussed.
静脉区域麻醉(IVRA)于1908年由德国外科医生奥古斯特·KG·比尔首次描述。尽管该技术操作简便且在提供手术麻醉方面有效,但由于IVRA的时间限制和安全考虑,更新的神经丛阻滞技术在短时间内基本上取代了“比尔阻滞”。多年来,已证明在操作上的改进和新的药物佐剂可预防对麻醉剂的毒性反应并减轻IVRA的局限性。本文回顾了该技术本身、其历史背景、为提高其安全性和效率而进行的操作改进、作用于麻醉起效时间和止血带疼痛的药物佐剂,以及改善术后镇痛和肌肉松弛的药物。还讨论了IVRA的经济方面。